Skip to main content
. 2023 Mar 7;13(3):e061294. doi: 10.1136/bmjopen-2022-061294

Figure 1.

Figure 1

Trial flow chart. Eligible and consenting participants will be randomised to an intervention or control arm and followed up for 12 months after surgery. DCM, degenerative cervical myelopathy; IMP, investigational medicinal product.